NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today said that revenues for the third quarter rose 3 percent year over year as it narrowly beat the consensus Wall Street estimates on the top and bottom lines.

The company took in $3.19 billion in total revenues for the three months ended Sept. 28, up from $3.09 billion a year ago, and edging out the average analyst estimate of $3.18 billion. Organically, revenues grew 2 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.